NCT00974792View on ClinicalTrials.gov

Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2011

Conditions
Lymphoma
Interventions
BIOLOGICAL

pegfilgrastim

BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

doxorubicin hydrochloride

DRUG

etoposide phosphate

DRUG

ifosfamide

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

vincristine sulfate

Trial Locations (1)

NG5 1PB

RECRUITING

Nottingham City Hospital, Nottingham

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER

NCT00974792 - Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter